Preoperative Nivolumab in Patients With Locally Advanced Colon Cancer (T3 or T4): a Window-of-opportunity Study

NCT04123925 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Colon Cancer Stage II/III

Interventions

DRUG: Nivolumab

Sponsor

National Cancer Institute, Naples